CN116730852A - Substituted phenyl isopropanolamine-containing compound, and preparation method and application thereof - Google Patents
Substituted phenyl isopropanolamine-containing compound, and preparation method and application thereof Download PDFInfo
- Publication number
- CN116730852A CN116730852A CN202310702493.2A CN202310702493A CN116730852A CN 116730852 A CN116730852 A CN 116730852A CN 202310702493 A CN202310702493 A CN 202310702493A CN 116730852 A CN116730852 A CN 116730852A
- Authority
- CN
- China
- Prior art keywords
- canker
- compound
- isopropanolamine
- substituted phenyl
- bacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 67
- -1 phenyl isopropanolamine Chemical class 0.000 title claims abstract description 36
- 229940102253 isopropanolamine Drugs 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 230000001580 bacterial effect Effects 0.000 claims description 32
- 150000003839 salts Chemical class 0.000 claims description 24
- 239000012453 solvate Substances 0.000 claims description 16
- 235000007164 Oryza sativa Nutrition 0.000 claims description 14
- 125000000217 alkyl group Chemical group 0.000 claims description 14
- 235000009566 rice Nutrition 0.000 claims description 14
- 241000207199 Citrus Species 0.000 claims description 13
- 235000020971 citrus fruits Nutrition 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 244000298697 Actinidia deliciosa Species 0.000 claims description 12
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 12
- 241000196324 Embryophyta Species 0.000 claims description 11
- 241000607479 Yersinia pestis Species 0.000 claims description 9
- 125000003118 aryl group Chemical group 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 125000001072 heteroaryl group Chemical group 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 244000052769 pathogen Species 0.000 claims description 8
- 230000001717 pathogenic effect Effects 0.000 claims description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- 208000035143 Bacterial infection Diseases 0.000 claims description 5
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 claims description 4
- 235000002566 Capsicum Nutrition 0.000 claims description 4
- 241000223218 Fusarium Species 0.000 claims description 4
- 239000006002 Pepper Substances 0.000 claims description 4
- 235000016761 Piper aduncum Nutrition 0.000 claims description 4
- 235000017804 Piper guineense Nutrition 0.000 claims description 4
- 244000203593 Piper nigrum Species 0.000 claims description 4
- 235000008184 Piper nigrum Nutrition 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 125000000304 alkynyl group Chemical group 0.000 claims description 3
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 244000061176 Nicotiana tabacum Species 0.000 claims description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 240000008067 Cucumis sativus Species 0.000 claims 4
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 4
- 239000000843 powder Substances 0.000 claims 3
- 229920002752 Konjac Polymers 0.000 claims 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims 2
- 208000031888 Mycoses Diseases 0.000 claims 2
- 240000007594 Oryza sativa Species 0.000 claims 2
- 241000233622 Phytophthora infestans Species 0.000 claims 2
- 241000221662 Sclerotinia Species 0.000 claims 2
- 240000003768 Solanum lycopersicum Species 0.000 claims 2
- 241000209140 Triticum Species 0.000 claims 2
- 235000021307 Triticum Nutrition 0.000 claims 2
- 235000009754 Vitis X bourquina Nutrition 0.000 claims 2
- 235000012333 Vitis X labruscana Nutrition 0.000 claims 2
- 240000006365 Vitis vinifera Species 0.000 claims 2
- 235000014787 Vitis vinifera Nutrition 0.000 claims 2
- 239000007864 aqueous solution Substances 0.000 claims 2
- 239000004495 emulsifiable concentrate Substances 0.000 claims 2
- 239000008187 granular material Substances 0.000 claims 2
- 235000010485 konjac Nutrition 0.000 claims 2
- 239000003094 microcapsule Substances 0.000 claims 2
- 239000004562 water dispersible granule Substances 0.000 claims 2
- 241000238631 Hexapoda Species 0.000 claims 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 claims 1
- 125000002723 alicyclic group Chemical group 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 230000000855 fungicidal effect Effects 0.000 claims 1
- 239000000417 fungicide Substances 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 230000002363 herbicidal effect Effects 0.000 claims 1
- 239000004009 herbicide Substances 0.000 claims 1
- 239000002917 insecticide Substances 0.000 claims 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 239000000779 smoke Substances 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 14
- 244000000005 bacterial plant pathogen Species 0.000 abstract description 11
- 230000005764 inhibitory process Effects 0.000 abstract description 11
- 244000000004 fungal plant pathogen Species 0.000 abstract description 3
- ISPYQTSUDJAMAB-UHFFFAOYSA-N 2-chlorophenol Chemical compound OC1=CC=CC=C1Cl ISPYQTSUDJAMAB-UHFFFAOYSA-N 0.000 abstract description 2
- 239000012634 fragment Substances 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 description 28
- 239000001963 growth medium Substances 0.000 description 14
- 241000209094 Oryza Species 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 11
- 239000003814 drug Substances 0.000 description 9
- 125000001424 substituent group Chemical group 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 238000005481 NMR spectroscopy Methods 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 241000813090 Rhizoctonia solani Species 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 241000123650 Botrytis cinerea Species 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 239000000575 pesticide Substances 0.000 description 6
- 125000005842 heteroatom Chemical group 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000008177 pharmaceutical agent Substances 0.000 description 4
- 230000003032 phytopathogenic effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000233866 Fungi Species 0.000 description 3
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 230000006907 apoptotic process Effects 0.000 description 3
- 125000002619 bicyclic group Chemical group 0.000 description 3
- 150000001716 carbazoles Chemical class 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 244000000003 plant pathogen Species 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000004308 thiabendazole Substances 0.000 description 3
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 3
- 229960004546 thiabendazole Drugs 0.000 description 3
- 235000010296 thiabendazole Nutrition 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 description 2
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 2
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241001290235 Ceratobasidium cereale Species 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000005868 Metconazole Substances 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 241000589655 Xanthomonas citri Species 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 229940125877 compound 31 Drugs 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical class C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000003113 dilution method Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- XWPZUHJBOLQNMN-UHFFFAOYSA-N metconazole Chemical compound C1=NC=NN1CC1(O)C(C)(C)CCC1CC1=CC=C(Cl)C=C1 XWPZUHJBOLQNMN-UHFFFAOYSA-N 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- 125000006168 tricyclic group Chemical group 0.000 description 2
- 230000001018 virulence Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 1
- JEESPINTVCBSTA-UHFFFAOYSA-N 1-(2-chlorophenoxy)propan-2-ol Chemical compound CC(O)COC1=CC=CC=C1Cl JEESPINTVCBSTA-UHFFFAOYSA-N 0.000 description 1
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical group CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 1
- QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 description 1
- CFTOTSJVQRFXOF-UHFFFAOYSA-N 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole Chemical class N1C2=CC=CC=C2C2=C1CNCC2 CFTOTSJVQRFXOF-UHFFFAOYSA-N 0.000 description 1
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 1
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 1
- ADVQMCQMDHBTHJ-UHFFFAOYSA-N 2-chloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=CC(Cl)=N1 ADVQMCQMDHBTHJ-UHFFFAOYSA-N 0.000 description 1
- 125000006512 3,4-dichlorobenzyl group Chemical group [H]C1=C(Cl)C(Cl)=C([H])C(=C1[H])C([H])([H])* 0.000 description 1
- BQXUPNKLZNSUMC-YUQWMIPFSA-N CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 Chemical compound CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 BQXUPNKLZNSUMC-YUQWMIPFSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 241001478342 Pseudomonas syringae pv. actinidiae Species 0.000 description 1
- 241000589652 Xanthomonas oryzae Species 0.000 description 1
- 241000907138 Xanthomonas oryzae pv. oryzae Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 150000001735 carboxylic acids Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000004803 chlorobenzyl group Chemical group 0.000 description 1
- 229940125851 compound 27 Drugs 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 125000006286 dichlorobenzyl group Chemical group 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 229960004242 dronabinol Drugs 0.000 description 1
- GKIPXFAANLTWBM-UHFFFAOYSA-N epibromohydrin Chemical compound BrCC1CO1 GKIPXFAANLTWBM-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000028644 hyphal growth Effects 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 238000005462 in vivo assay Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000575 proteomic method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000002755 pyrazolinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Chemical group COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 125000006413 ring segment Chemical group 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229960002385 streptomycin sulfate Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000011885 synergistic combination Substances 0.000 description 1
- CWXPZXBSDSIRCS-UHFFFAOYSA-N tert-butyl piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNCC1 CWXPZXBSDSIRCS-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
- A01N33/02—Amines; Quaternary ammonium compounds
- A01N33/08—Amines; Quaternary ammonium compounds containing oxygen or sulfur
- A01N33/10—Amines; Quaternary ammonium compounds containing oxygen or sulfur having at least one oxygen or sulfur atom directly attached to an aromatic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/06—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
- A01N43/08—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings with oxygen as the ring hetero atom
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/06—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
- A01N43/10—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings with sulfur as the ring hetero atom
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/62—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms three- or four-membered rings or rings with more than six members
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P3/00—Fungicides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/04—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/58—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Environmental Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The application relates to a compound containing substituted phenyl isopropanolamine, a preparation method and application thereof. The compound has a structure shown in a general formula (I):
Description
Technical Field
The application relates to the technical field of pharmaceutical chemistry, in particular to a compound containing substituted phenyl isopropanolamine, and a preparation method and application thereof.
Background
Plant bacterial diseases are one of the main factors affecting global agricultural production, seriously affect the yield and quality of agricultural products, cause great economic loss and threaten human health. Such as bacterial leaf blight of rice, canker of citrus, canker of kiwi fruit, bacterial wilt of tobacco and the like, outbreaks to different degrees each year, and causes huge economic loss for farmers. The long-term use of traditional bactericides such as thiabendazole, metconazole, streptomycin sulfate and the like not only increases the drug resistance of plant pathogenic bacteria, but also has harmful effects on the ecological environment and the safety of plants. Therefore, there is an urgent need to develop a novel pesticide having high activity and high selectivity.
In order to find an active compound with high-efficiency sterilization, the application takes substituted phenyl as a parent ring, connects propylene oxide, and then uses amine compounds to open the ring to obtain a target compound with isopropanolamine structure, synthesizes a series of compounds with novel structure and substituted phenyl isopropanolamine, tests the biological activity of the compounds, and provides an important scientific basis for the research and development and the creation of new pesticides.
The study of the biological activity of the substituted phenyl compounds proceeds as follows:
in 2019, zhao et al [ Zhao, yong Liang; huang, xing; liu, li Wei; wang, pei Yi; long, qing Su; tao, qing; li, zhong; yang, song. Identification of Racemic and Chiral Carbazole Derivatives Containing an Isopropanolamine Linker as Prospective Surrogates against Plant Pathogenic Bacteria: in Vitro and In Vivo Assays and Quantitative Proteomics [ J].J.Agric.Food Chem.,2019,67(26),7512-7525.]The design and synthesis of the raceme chiral carbazole derivatives show that the compound 26 can obviously inhibit the growth of rice bacterial blight bacteria, citrus canker bacteria and kiwi fruit canker bacteria of plant pathogenic bacteria to be tested and the EC thereof 50 The values are 2.04, 2.42 and 0.603 mug/mL respectively, which is significantly better than the existing commercial medicines. In vivo studies prove that they have application prospects in the aspect of controlling plant bacterial diseases. Label-free quantitative proteomic analysis showed that compound 27 could significantly induce up-and down-regulation of 247 differentially expressed proteins, and this result was further confirmed by parallel reaction monitoring techniques.
In 2019, xiang et al [ Xiang, meng; zhou, xiang; luo, ting Rong; wang, pei Yi; liu, li Wei; li, zhong; wu, zhi big; yang, song. Design, synthesis, antibacterial Evaluation, and Induced Apoptotic Behaviors of Epimeric andChiral 18β-Glycyrrhetinic Acid Ester Derivatives with an Isopropanolamine Bridge against Phytopathogens[J].J.Agric.Food Chem.,2019,67(48),13212-13220.]a series of 18 beta-glycyrrhetinic acid ester derivatives with different tertiary amines are designed and synthesized, and the pharmacological activity of the 18 beta-glycyrrhetinic acid ester derivatives is screened. The results showed that compounds 28, 29 were effective against plant pathogens Xanthomonas oryzae and Xanthomonas citri (EC) 50 3.81 and 2.76 mug/mL respectively) are superior to GA (EC) 50 > 400 μg/mL), thiabendazole and metconazole. Pharmacophore studies have shown that the synergistic combination of the GA backbone with tertiary amine scaffolds contributes to biological effects. In vivo experiments show their application prospects in controlling bacterial infections. The antibacterial mechanism research shows that the title compound can induce apoptosis of the tested pathogen, and the observed bacterial morphology change in the scanning electron microscope image is obvious. This result will facilitate the development of various apoptosis inducers.
In 2020, liu et al [ Liu, hong Wu; ji, qing Tian; ren, gang; wang, fang; su, fen; wang, pei Yi; zhou, xiang; wu, zhi big; li, zhong; an array of novel THC derivatives of 1,3-Diaminopropan-2-ol were prepared by Yang, song.antibacterial Functions and Proposed Modes of Action of Novel 1,2,3,4-tetrahydroβ -carboline Derivatives that Possess an Attractive, 3-diaminoprop-2-ol Pattern against Rice Bacterial Blight, kiwifruit Bacterial Canker, and Citrus Bacterial Canker [ J ]. J.agric.food chem.,2020, 68 (45), 12558-12568 ], and evaluated for biological activity, target compound 30 was used for three plant pathogens: the bacterial leaf blight bacteria, the citrus canker bacteria and the kiwi fruit canker bacteria all show excellent activity. . The relevant EC50 values were 1.69, 4.05 and 2.39. Mu.g/mL, respectively. The effect is better than that of the parent structure 1,2,3,4-THC and positive control. The antibacterial mechanism shows that tetrahydrocannabinol compounds can induce the increase of active oxygen of bacteria, so that the bacteria have obvious apoptosis behaviors. In addition, compound 30 may reduce hypersensitivity and pathogenicity of kiwifruit canker pathogens.
2021, huang et al [ Huang, xing; liu, hong Wu; long, zhou Qing; li, zhen Xing; zhu, jian Jun; wang, pei Yi; qi, pu Ying; liu, li Wei; 1,2,3-Triazole custom carbazole was prepared by Yang, song.RationalOptimation of 1,2,3-Triazole-Tailored Carbazoles As Prospective Antibacterial Alternatives with Significant In Vivo Control Efficiency and Unique Mode of Action [ J ]. J.Agric.Food chem.,2021, 69 (16), 4615-4627 ]. The compounds have inhibition effect on the growth of bacterial leaf blight bacteria, citrus canker bacteria and kiwifruit canker bacteria of rice, and EC50 values are respectively 3.36 (31), 2.87 (31) and 4.57 mug/mL (32). The potting test results show that the control effect of the compound 31 on the bacterial leaf blight of rice at the concentration of 200 mug/mL is 53.23% and 50.78% respectively. Interestingly, the addition of 0.1% of adjuvants such as organosilicon and orange oil can significantly improve the surface wettability of the compound 31 on rice leaves, and the control effect is respectively improved by 65.50% and 61.38%. Meanwhile, the compound 32 has obvious inhibition effect on white suppurative secretion caused by kiwi fruit canker pathogen infection, and the control effect of the compound is 79.42 percent (protective activity) and 78.74 percent (therapeutic activity) respectively at the concentration of 200 mug/mL, which is obviously better than that of the commercial pesticide thiabendazole copper.
Disclosure of Invention
The application provides a compound containing substituted phenyl isopropanolamine or a stereoisomer thereof or a salt thereof or a solvate thereof.
It is another object of the present application to provide an intermediate compound for preparing the above compound or a stereoisomer thereof, or a salt thereof or a solvate thereof, and a method for preparing the same.
It is still another object of the present application to provide a composition comprising the above compound or a stereoisomer thereof, or a salt thereof or a solvate thereof.
It is a further object of the present application to provide the use of the above compound or a stereoisomer thereof, or a salt thereof or a solvate thereof, or the composition.
It is another object of the present application to provide a method for controlling agricultural pests using the above-mentioned compound or a stereoisomer thereof, or a salt thereof or a solvate thereof, or the composition.
In order to achieve the above purpose, the present application adopts the following technical scheme:
a compound containing substituted phenyl isopropanolamine or a stereoisomer thereof, or a salt thereof or a solvate thereof, the compound having a structure as shown in a general formula (I):
wherein R is 1 、R 2 And R is 3 Each independently selected from hydrogen and chlorine; r is R 4 、R 5 Each independently selected from one or more of hydrogen, optionally substituted or unsubstituted alkyl, amino, optionally substituted or unsubstituted aryl, optionally substituted or unsubstituted heteroaryl;
the application also provides a preparation method of the compound containing the substituted phenyl isopropanolamine or the stereoisomer thereof, or the salt or the solvate thereof, which comprises the following steps:
the term "alkyl" as used herein is intended to include both branched and straight chain saturated hydrocarbon groups having a specified number of carbon atoms. For example "C 1-10 Alkyl "(or alkylene) is intended to mean C1, C2, C3, C4, C5, C6, C7, C8, C9 and C10 alkyl. In addition, e.g. "C 1-6 Alkyl "means an alkyl group having 1 to 6 carbon atoms. Alkyl groups may be unsubstituted or substituted such that one or more of its hydrogen atoms is replaced by another chemical group. Examples of alkyl groups include, but are not limited to, methyl (Me), ethyl (Et), propyl (e.g., n-propyl and isopropyl), butyl (e.g., n-butyl, isobutyl, t-butyl), pentyl (e.g., n-pentyl, isopentyl, neopentyl) and the like.
The term "substituted" as used herein refers to any one or more hydrogen atoms on a specified atom or group being replaced with a selected specified group, provided that the specified atom's general valency is not exceeded. Substituents are named to the central structure, unless otherwise indicated. For example, it is understood that when (cycloalkyl) alkyl is the possible substituent, the point of attachment of the substituent to the central structure is in the alkyl moiety. As used herein, a ring double bond is a double bond formed between two adjacent ring atoms (e.g., c= C, C =n or n=n). When referring to substitution, particularly polysubstituted, it is meant that a plurality of substituents are substituted at various positions on the indicated group, such as dichlorobenzyl refers to 2, 3-dichlorobenzyl, 2, 4-dichlorobenzyl, 2, 5-dichlorobenzyl, 2, 6-dichlorobenzyl, 3, 4-dichlorobenzyl and 3, 5-dichlorobenzyl.
Combinations of substituents and variables are permissible only if such combinations result in stable compounds or useful synthetic intermediates. The stable compound or stable structure implies that the compound is sufficiently stable when isolated from the reaction mixture in useful purity, and is formulated to form an effective therapeutic agent.
The term "heteroaryl" refers to substituted and unsubstituted aromatic 5-or 6-membered monocyclic groups, 9-or 10-membered bicyclic groups, and 11 to 14-membered tricyclic groups, having at least one heteroatom (O, S or N) in at least one ring, said heteroatom-containing ring preferably having 1,2 or 3 heteroatoms selected from O, S and N. Each ring of the heteroatom-containing heteroaryl group may contain one or two oxygen or sulfur atoms and/or from 1 to 4 nitrogen atoms provided that the total number of heteroatoms in each ring is 4 or less and that each ring has at least one carbon atom. The fused ring completing the bicyclic and tricyclic groups may contain only carbon atoms and may be saturated, partially saturated, or unsaturated. The nitrogen may optionally be oxidized and quaternized. Bicyclic or tricyclic heteroaryl groups must include at least one wholly aromatic ring and the nitrogen other fused rings may be aromatic or non-aromatic. Heteroaryl groups may be attached at any available nitrogen or carbon atom of any ring.
Exemplary monocyclic heteroaryl groups include pyrrolyl, pyrazolyl, pyrazolinyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, thiadiazolyl, furanyl, thienyl, oxadiazolyl, pyridinyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl, and the like.
The compounds of the present application are understood to include both the free form and salts thereof, unless otherwise indicated. The term "salt" means an acid and/or base salt formed from inorganic and/or organic acids and bases. In addition, the term "salt" may include zwitterionic (inner salts), such as when the compounds of formula I contain basic moieties such as amine or pyridine or imidazole rings, and acidic moieties such as carboxylic acids. Pharmaceutically acceptable (i.e., non-toxic, physiologically acceptable) salts are preferred, such as acceptable metal and amine salts, wherein the cation does not contribute significantly to the toxicity or bioactivity of the salt. However, other salts may be useful, such as by employing isolation or purification steps in the preparation process, and are therefore also included within the scope of the present application.
Preferably C 1 -C 10 Alkyl refers to methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl and isomers thereof;
when referring to substituents as alkynyl, alkyl, aryl, benzyl, or where these substituents are specifically a particular alkynyl, alkyl, aryl, benzyl, cycloalkyl, one to three of the above substituents are meant. For example chlorobenzyl refers to one to three chloro-substituted benzyl groups.
By adopting the technical scheme, the application takes the substituted phenyl as the starting material to synthesize a series of compounds containing the substituted phenyl isopropanolamine, and the compounds are found to have good inhibition effect on pathogenic bacteria of pathogenic plants, have good inhibition effect on pathogenic bacteria [ such as bacterial leaf blight bacteria (Xanthomonas oryzae pv. Oryzae, xoo), citrus canker (Xanthomonas axonopodis pv. Citri, xac) and kiwi fruit canker (Pseudomonas syringae pv. Actinidiae, psa) and the like ], and have good inhibition effect on pathogenic fungi [ such as Botrytis cinerea, rhizoctonia solani and the like ], and provide important scientific basis for research and development and creation of new pesticides.
Examples
The application is further illustrated by the following examples. It should be understood that the methods described in the examples of the present application are only for illustrating the present application, and not for limiting the present application, and that simple modifications to the preparation methods of the present application under the concept of the present application are within the scope of the present application as claimed. All the starting materials and solvents used in the examples are commercially available products.
Example 1: preparation of intermediate 2- (2-chlorophenoxy) methyl oxirane
2-chlorophenol (15.56 mmol) and K 2 CO 3 (18.67 mmol) was added to a 100mL round bottom flask, 20mL DMF was added thereto, stirred at 60℃for 15 minutes, then epibromohydrin (23.34 mmol) was slowly added dropwise to the system, and the reaction was stopped after 5 hours; ethyl acetate (60 mL) was added, followed by saturated NH 4 Aqueous Cl (3X 30 mL) was washed, and the organic phase was collected over anhydrous Na 2 SO 4 Drying, desolventizing, column chromatography (PE: ea=10:1, V/V) gave a colorless liquid in 87.74% yield. The nuclear magnetic data are as follows: 1 H NMR(400MHz,CDCl 3 )δ7.36(dd,J=1.6Hz,1H,phenyl-H),7.22-7.18(m,1H,phenyl-H),6.96-6.89(m,2H,phenyl-H),4.29(dd,J=2.8Hz,1H,phenyl-O-CH 2 -),4.05(dd,J=5.6Hz,1H,phenyl-O-CH2-),3.41-3.37(m,1H,-O-CH-),2.93-2.90(t,J=4.8Hz,1H,-O-CH 2 -),2.83(dd,J=2.8Hz,1H,-O-CH 2 -). 13 C NMR(101MHz,CDCl 3 )δ154.1,130.5,127.8,123.2,122.2,114.0,69.7,50.2,44.8.
example 2: preparation of intermediate 4- (3- (2-chlorophenoxy) -2-hydroxypropyl) -1-tert-butoxycarbonyl piperazine
2- (2-chlorophenoxy) methyl oxirane (2.71 mmol) and K 2 CO 3 (18.67 mmol) was dissolved in 4mL of isopropanol solution, then 1-t-butoxycarbonyl piperazine (2.98 mmol) was added and reacted at 60 ℃. The TCL tracks the reaction until completion. Dichloromethane (20 mL) was added, washed with water (3×15 mL), and the organic phase was collected over anhydrous Na 2 SO 4 Drying, desolventizing, column chromatography (DCM: m=50:1, V/V) gave a yellow oil in 96.15% yield. The nuclear magnetic data are as follows: 1 H NMR(400MHz,CDCl 3 )δ7.33(dd,J=7.9,1.6Hz,1H,phenyl-H),7.19(ddd,J=8.3,7.6,1.6Hz,1H,phenyl-H),6.93(dd,J=8.3,1.2Hz,1H,phenyl-H),6.89(td,J=7.7,1.3Hz,1H,phenyl-H),4.14(td,J=9.3,4.7Hz,1H,-O-CH-),4.04(d,J=4.9Hz,2H,-CH-CH 2 -piperazinyl),3.46-3.40(m,4H,piperazinyl-H),2.64-2.55(m,4H,piperazinyl-H),2.45-2.37(m,2H,phenyl-O-CH 2 -),1.44(s,9H,-C(CH 3 ) 3 ). 13 C NMR(101MHz,CDCl 3 )δ154.8,154.3,130.3,127.8,123.1,121.9,113.9,79.8,71.3,65.8,60.7,53.3,28.5,25.4.
example 3: preparation of intermediate 1- (2-chlorophenoxy) -3- (piperazin-1-yl) propanol
4- (3- (2-chlorophenoxy) -2-hydroxypropyl) -1-t-butoxycarbonylpiperazine (5.39 mmol) was dissolved in 10mL DCM and put into a 50mL round bottom flask, concentrated hydrochloric acid (5.39 mmol) was slowly added dropwise to the reaction system and stirred at room temperature for 2h. TLC tracing, desolventizing after completion of the reaction, adding 10mL of water, then K 2 CO 3 Adjusting pH to 9-10, and desolventizing to obtain yellow solid with a yield of 95.88%. The nuclear magnetic data are as follows: 1 H NMR(400MHz,CDCl 3 )δ7.35(dd,J=7.9,1.5Hz,1H,phenyl-H),7.22-7.17(m,1H,phenyl-H),6.95(dd,J=8.3,1.2Hz,1H,phenyl-H),6.93-6.86(m,1H,phenyl-H),4.17-4.10(m,1H,-O-CH-),4.04(d,J=5.0Hz,2H,-CH-CH 2 -piperazinyl),3.03-2.77(m,4H,piperazinyl-H),2.74-2.64(m,2H,piperazinyl-H),2.61-2.57(m,2H,phenyl-O-CH 2 -),2.49-2.37(m,2H,piperazinyl-H). 13 C NMR(101MHz,CDCl 3 )δ154.4,130.4,127.8,123.2,121.9,113.9,71.6,65.5,61.2,51.6,46.2.
example 4: preparation of the target Compound 3,3' -Ethylazadiylbis (1- (2-chlorophenoxy) propan-2-ol)
2- (2-chlorophenoxy) methyl oxirane (1.62 mmol) and K 2 CO 3 (0.81 mmol) was dissolved in 4mL of isopropanol solution, then ethylamine (0.81 mmol) was added and reacted at 60 ℃. The TCL tracks the reaction until completion. Quench the reaction with water (15 mL) followed by CH 2 Cl 2 (30 mL) extraction, washing with water (2X 30 mL), and washing the organic phase with anhydrous Na 2 SO 4 After drying, desolventizing and column chromatography (DCM: m=60:1, V/V) gave a white solid in 79 yield.28%。
Example 5: a target compound: 1- (2-chlorophenoxy) -3- (4- (3-trifluoromethylphenyl) piperazin-1-yl) propanol 1- (2-chlorophenoxy) -3- (piperazin-1-yl) propanol (1.11 mmol) and Cs 2 CO 3 (1.33 mmol) was dissolved in 4mL of DMSO solution, then 2-chloro-6-trifluoromethylpyridine (1.11 mmol) was added and reacted at 105 ℃. TCL followed the reaction until completion, then extracted with ethyl acetate (30 mL), washed with water (4X 15 mL), and the organic phase was washed with anhydrous Na 2 SO 4 After drying, desolventizing and column chromatography (DCM: m=100:1, V/V) gave a white solid in 53.17% yield.
Other target compounds were synthesized using the corresponding starting materials or substituents, with reference to the procedure of the examples described above.
The structure and nuclear magnetic resonance hydrogen spectrum and carbon spectrum data of the synthesized compound containing the substituted phenyl isopropanolamine are shown in table 1, and the physical and chemical properties are shown in table 2.
TABLE 1 Nuclear magnetic resonance Hydrogen Spectroscopy and carbon Spectroscopy data for the Compounds of the application
/>
/>
/>
/>
/>
/>
TABLE 2 physicochemical Properties of the Compounds of the application
/>
Pharmacological example 1:
EC 50 (median effective concentration) is an important index for evaluating the sensitivity of plant pathogenic bacteria to a compound, and is also an important parameter for setting the concentration of the compound when researching the action mechanism of the target compound. In the concentration gradient experiment, proper 5 concentrations are set by adopting a double dilution method, and finally the inhibition rate of the medicament to plant pathogenic bacteria and the medicament concentration are converted into logarithmic values, and the virulence curve is obtained by SPSS software regression analysis, so that EC is calculated 50 。
By using turbid materialsMethod for testing effective medium concentration EC of target compound on plant pathogenic bacteria 50 The test subjects were rice bacterial leaf blight bacteria (Xoo), citrus canker bacteria (Xac) and kiwi fruit canker bacteria (Psa). DMSO was dissolved in the medium as a blank. Putting rice bacterial leaf blight bacteria (rice bacterial leaf blight pathogenic bacteria are in an M210 solid culture medium) into an NB culture medium, and carrying out shake culture in a constant-temperature shaking table at 28 ℃ and 180rpm until the bacterial leaf blight bacteria are in a logarithmic growth phase for later use; the citrus canker fungus (on M210 solid medium) is placed in NB medium and shake-cultured in a thermostatic shaker at 28℃and 180rpm until logarithmic growth phase is ready for use. 5mL of toxic NB liquid culture medium with different concentrations (for example, 100, 50, 25 and 12.5,6.25 mug/mL) of the medicament (compound) is added into a test tube, 40 mu L of NB liquid culture medium containing phytopathogenic bacteria is respectively added, and the culture is oscillated in a constant temperature shaking table at 28 ℃ and 180rpm, so that the rice bacterial leaf blight pathogenic bacteria are cultured for 36h, the citrus canker bacteria are cultured for 48h and the kiwi fruit canker bacteria are cultured for 36h. Measuring OD of bacterial solutions with various concentrations on a spectrophotometer 595 Values, and additionally determining the OD of corresponding concentrations of toxic sterile NB liquid medium 595 Values.
Corrected OD = bacteria-containing medium OD-sterile medium OD
Inhibition ratio = [ (corrected control culture medium bacterial liquid OD value-corrected toxic culture medium OD value)/corrected control culture medium bacterial liquid OD value ] ×100
The present application is described with the aid of examples, but the contents of examples are not limited thereto, and the experimental results of the target compounds are shown in table 3.
TABLE 3 inhibitory Activity of the Compounds of the application against phytopathogenic bacteria
/>
TABLE 4 EC of the compounds of the application against phytopathogenic bacteria 50
/>
"NT" means not tested
As can be seen from Table 4, the target compounds showed good inhibitory activity against plant pathogenic bacteria (such as Rhizoctonia solani, rhizoctonia cerealis and Rhizoctonia cerealis) in an in vitro test. Wherein most of compounds containing benzyl and phenyl in the structure have EC on bacterial leaf blight bacteria and citrus canker bacteria of rice 50 Within 20, especially the compound 28 has excellent activity on rice bacterial leaf blight bacteria and citrus canker bacteria, and EC 50 3.57 and 1.70 μg/mL, respectively; therefore, the compound has great research prospect and can be used for preparing pesticides against plant pathogenic bacteria.
Pharmacological example 2:
EC 50 (median effective concentration) is an important index for evaluating the sensitivity of plant pathogenic bacteria to a compound, and is also an important parameter for setting the concentration of the compound when researching the action mechanism of the target compound. In the concentration gradient experiment, proper 5 concentrations are set by adopting a double dilution method, and finally the inhibition rate of the medicament to plant pathogenic bacteria and the medicament concentration are converted into logarithmic values, and the virulence curve is obtained by SPSS software regression analysis, so that EC is calculated 50 。
Test of the effective Medium concentration EC of the target Compounds against plant pathogens Using the hyphal growth Rate method 50 The test subjects were Botrytis cinerea (B.d), pepper fusarium wilt (F.o) and Rhizoctonia solani (R.s). Placing the Botrytis cinerea (the Botrytis cinerea is in a PDA solid culture medium) into the PDA culture medium, and culturing in a 28 ℃ incubator for 48 hours for later use; placing pepper fusarium wilt bacteria (in a PDA solid culture medium) into a PDA culture medium, and culturing in a 28 ℃ incubator for 48 hours for later use; rhizoctonia solani (in PDA solid)Culture medium) is placed in PDA culture medium, and is cultivated in a culture box at 28 ℃ for 48 hours for standby; the pharmaceutical agent (compound) was prepared as a pharmaceutical agent dilution of different concentrations (e.g., 50, 25, 12.5,6.25,3.125. Mu.g/mL), and PDA drug-containing plates were prepared at a ratio of 9:1 with the pharmaceutical agent dilutions of different concentrations, and the treatment without adding the pharmaceutical agent was used as a control. Preparing bacterial cake at the edge of the activated colony by using a puncher with the inner diameter of 5mm, inoculating a loop to the center of the PDA culture medium of each medicament concentration and control, placing the bacterial cake in a constant temperature incubator for 2-3 d, and measuring the diameter of each colony by using a crisscross method when the control colony grows up to the whole culture dish. The inhibition of each agent was calculated for the different fungi.
Hypha growth inhibition ratio = [ (control colony diameter-agent-treated colony diameter)/control colony diameter-5 ] ×100
The present application is described with the aid of examples, but the contents of examples are not limited thereto, and the experimental results of the target compounds are shown in table 5.
TABLE 5 inhibitory Activity of the Compounds of the application against phytopathogenic fungi
/>
As can be seen from Table 5, the target compounds were inferior in the in vitro test in the inhibition activity against plant pathogenic fungi (Botrytis cinerea, rhizoctonia solani and Rhizoctonia solani). Wherein, the inhibitory activity of the compounds 11 and 46 on the Botrytis cinerea at the concentration of 50 mug/mL is 78.50% and 83.95%, respectively; the inhibitory activities of compounds 13 and 18 on Rhizoctonia solani at 50 μg/mL were 72.99% and 70.08%, respectively; can be used for preparing pesticides against plant pathogenic fungi.
Claims (9)
1. A class of compounds containing substituted phenyl isopropanolamine or stereoisomers thereof, or salts or solvates thereof, is characterized in that: the compound has a structure shown in a general formula (I):
wherein R is 1 、R 2 And R is 3 Each independently selected from hydrogen, halogen or alkyl; r is R 4 、R 5 One of which may optionally be absent or each independently selected from one or more of hydrogen, optionally substituted or unsubstituted alkyl, optionally substituted or unsubstituted alkenyl, optionally substituted or unsubstituted alkynyl, optionally substituted or unsubstituted aryl, optionally substituted or unsubstituted heteroaryl;
or R is 4 、R 5 Bonding to form an alicyclic, aromatic or heteroaromatic ring;
n=1、2、3。
2. the substituted phenyl-containing isopropanolamine compound or its stereoisomers, or its salts or its solvates according to claim 1, wherein:
R 1 、R 2 and R is 3 Each independently selected from hydrogen, F, cl, br, methyl;
R 4 、R 5 one of which may optionally be absent, or
Each independently selected from the group consisting of hydrogen, methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, phenyl, benzyl, adamantyl,
n=1、2、3。
3. The substituted phenyl isopropanolamine-containing compound or its stereoisomers, or its salts or its solvates according to claim 1, characterized by being selected from the following compounds:
4. an intermediate compound for preparing the substituted phenyl isopropanolamine compound or its stereoisomers, or salts or solvates thereof according to claim 1, which is characterized by the following formula:
5. a process for the preparation of a substituted phenyl isopropanolamine-containing compound or its stereoisomers, or a salt thereof or a solvate thereof, according to any of claims 1 to 3, comprising the steps of:
preferably, the method further comprises the steps of:
wherein R is 1 、R 2 、R 3 、R 4 、R 5 The method of claim 1.
6. A composition comprising a compound according to any one of claims 1 to 3 or a stereoisomer thereof, or a salt thereof or a solvate thereof, and an agriculturally acceptable adjuvant or fungicide, insecticide or herbicide; preferably, the formulation of the composition is selected from the group consisting of Emulsifiable Concentrates (EC), powders (DP), wettable Powders (WP), granules (GR), aqueous Solutions (AS), suspensions (SC), ultra low volume sprays (ULV), soluble Powders (SP), microcapsules (MC), smoke agents (FU), aqueous Emulsions (EW), water dispersible granules (WG).
7. Use of a compound according to any one of claims 1 to 3, or a stereoisomer thereof, or a salt thereof, or a solvate thereof, or a composition according to claim 6, for controlling an agricultural pest, preferably a plant bacterial or fungal disease; more preferably, the agricultural pest is a plant leaf blight and a plant canker; most preferably, the agricultural pest is rice bacterial leaf blight, cucumber bacterial leaf blight, konjak bacterial leaf blight, citrus canker, kiwi fruit canker, grape canker, tomato canker, apple canker, cucumber gray mold pathogen, pepper fusarium wilt pathogen, rape sclerotinia rot, wheat red mold pathogen, potato late blight pathogen.
8. A method for controlling agricultural plant diseases and insect pests, which is characterized by comprising the following steps: allowing a compound according to any one of claims 1 to 3 or a stereoisomer thereof, or a salt thereof or a solvate thereof, or a composition according to claim 6 to act on a pest or a living environment thereof; preferably, the pest is a plant bacterial or fungal disease; more preferably, the pest is rice bacterial leaf blight, tobacco bacterial wilt, cucumber bacterial leaf blight, konjak bacterial leaf blight, citrus canker, kiwi fruit canker, grape canker, tomato canker, apple canker, cucumber gray mold, pepper fusarium wilt pathogen, rape sclerotinia rot, wheat red mold pathogen, potato late blight pathogen.
9. A method for protecting plants from agricultural pests comprising the method step wherein the plants are contacted with a compound according to any one of claims 1 to 3 or a stereoisomer thereof, or a salt thereof or a solvate thereof, or a composition according to claim 6.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310702493.2A CN116730852A (en) | 2023-06-14 | 2023-06-14 | Substituted phenyl isopropanolamine-containing compound, and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310702493.2A CN116730852A (en) | 2023-06-14 | 2023-06-14 | Substituted phenyl isopropanolamine-containing compound, and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116730852A true CN116730852A (en) | 2023-09-12 |
Family
ID=87918103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310702493.2A Pending CN116730852A (en) | 2023-06-14 | 2023-06-14 | Substituted phenyl isopropanolamine-containing compound, and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116730852A (en) |
-
2023
- 2023-06-14 CN CN202310702493.2A patent/CN116730852A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109627206B (en) | Preparation method and application of carbazolyl isopropanolamine derivatives with chiral centers | |
CN111454260B (en) | 1,2,3,4-tetrahydro-beta-carboline compounds containing isopropanolamine substructure as well as preparation method and application thereof | |
CN112608307B (en) | Heterocyclic substituted 1,3,4-oxadiazole hydrazide compound as well as preparation method and application thereof | |
CN112592335A (en) | Carbazole isopropanol diamine compound containing 1, 2, 3-triazole and preparation method and application thereof | |
CN113636984B (en) | Morpholine group-containing 1,3, 4-oxadiazole compound and preparation method and application thereof | |
CN111285814B (en) | Quinazolinone compound containing hydrazone structural unit or stereoisomer thereof, or salt or solvate thereof | |
CN108314679B (en) | Bactericide containing 1,3, 4-oxadiazole ring stilbene amide and preparation method and application thereof | |
CN111377870B (en) | 2, 4-dioxoimidazolines cyclohexane sulfonamide compounds, process for their preparation and their use as fungicides or bactericides | |
CN110776548B (en) | Acetoxy ursolic acid piperazine compounds containing isopropanolamine substructure as well as preparation method and application thereof | |
CN116082240A (en) | Succinate dehydrogenase inhibitor and synthesis method and application thereof | |
CN113563281B (en) | Benzophenone compound containing 1,3, 4-thiadiazole thioether structure and application thereof | |
CN116730852A (en) | Substituted phenyl isopropanolamine-containing compound, and preparation method and application thereof | |
CN115536543B (en) | Triclosan compound containing isopropanolamine structure and preparation method and application thereof | |
CN113620894A (en) | Oxadiazole thioether compounds containing amide substructure as well as preparation method and application thereof | |
CN115197131A (en) | Azo 2-amino benzyl nicotinate derivative and preparation method and application thereof | |
KR100427262B1 (en) | Fungicidal methoxy acrylate derivatives containing sulfur | |
CN106045982A (en) | N'-5-(substituted-phenyl)-2-furanmethenyl-5-propyl-1H-pyrazol-3-ethyl formate compound and preparation method and application thereof | |
CN107033134B (en) | Bisamide compound containing pyridinium and 1,3, 4-oxadiazolyl and preparation method and application thereof | |
CN115521306B (en) | 1,2,3, 4-tetrahydro-beta-carboline derivative and preparation method and application thereof | |
CN112624962B (en) | Carbazolyl isopropanolamine derivatives with double chiral centers and preparation method and application thereof | |
CN111393359A (en) | Pyridine salt-containing N- (cinnamoyl) -N' - (substituted) propyl hydrazide compound and preparation method and application thereof | |
CN114957215B (en) | Methylene bridged quinoline and 1,2, 3-triazole diheterocyclic compound and preparation method and application thereof | |
CN116730954A (en) | Isopropanolamine compound containing chalcone structure, and preparation method and application thereof | |
CN113999222B (en) | Adamantyl oxadiazole-containing compound and preparation method and application thereof | |
CN114773328A (en) | Oxadiazole-containing thioether and sulfone compound, stereoisomer thereof, salt thereof or solvate thereof, preparation method, composition and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |